Tag: 1year

Stock

Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment o

31/05/2025
admin

Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary…

Stock

Asian spot prices slip to near 1-year low on weak demand, recession concerns

12/04/2025
admin

Asian spot prices slip to near 1-year low on weak demand, recession concerns#Asian #spot #prices #slip…